Abstract
ABSTRACT We recently described a new method to activate antibiotic production in bacteria by introducing a mutation conferring resistance to a drug such as streptomycin, rifampin, paromomycin, or gentamicin. This method, however, enhanced antibiotic production by only up to an order of magnitude. Working with Streptomyces coelicolor A3(2), we established a method for the dramatic activation of antibiotic production by the sequential introduction of multiple drug resistance mutations. Septuple and octuple mutants, C7 and C8, thus obtained by screening for resistance to seven or eight drugs, produced huge amounts (1.63 g/liter) of the polyketide antibiotic actinorhodin, 180-fold higher than the level produced by the wild type. This dramatic overproduction was due to the acquisition of mutant ribosomes, with aberrant protein and ppGpp synthesis activity, as demonstrated by in vitro protein synthesis assays and by the abolition of antibiotic overproduction with relA disruption. This new approach, called “ribosome engineering,” requires less time, cost, and labor than other methods and may be widely utilized for bacterial strain improvement.
References
37
Referenced
122
10.1016/S1369-5274(99)00005-3
10.1016/S0092-8674(04)00401-5
10.1046/j.1365-2958.2003.03307.x
- Cashel, M., D. R. Gentry, V. J. Hernandez, and D. Vinella. 1996. The stringent response, p. 1458-1496. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, DC. / Escherichia coli and Salmonella: cellular and molecular biology (1996)
10.1128/jb.179.18.5854-5861.1997
10.1074/jbc.M311573200
10.1111/j.1365-2958.2006.05266.x
10.1111/j.1365-2958.1993.tb01174.x
10.7164/antibiotics.50.532
10.1046/j.1365-2958.2001.02221.x
10.1186/gb-2007-8-8-r161
10.1111/j.1365-2958.2006.05285.x
10.1046/j.1462-2920.2002.00348.x
10.1128/AAC.42.8.2041
10.1128/AEM.67.4.1885-1892.2001
10.1128/JB.184.14.3984-3991.2002
10.1101/gad.943401
10.1007/BF00382280
10.1074/jbc.M208722200
10.1074/jbc.M309925200
10.1128/JB.00574-06
- Practical Streptomyces genetics. 2000
10.1128/AEM.72.1.71-77.2006
10.1128/jb.154.2.787-792.1983
10.1046/j.1365-2958.2000.01967.x
10.1128/JB.01776-06
10.1128/jb.169.8.3608-3616.1987
10.1099/00221287-136-12-2405
10.1016/S0065-2164(04)56005-7
10.7164/antibiotics.53.1424
10.1006/jmbi.1997.1541
10.1128/jb.178.24.7276-7284.1996
10.1073/pnas.0308555101
10.1128/AEM.69.11.6412-6417.2003
10.1073/pnas.97.7.3747
- Wilson, D. N. 2004. Antibiotics and the inhibition of ribosome function, p. 449-527. In D. N. Wilson and K. H. Niehaus (ed.), Protein synthesis and ribosome structure: translating the genome. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. / Protein synthesis and ribosome structure: translating the genome. (2004)
10.1016/S0076-6879(06)15012-0
Dates
Type | When |
---|---|
Created | 17 years, 6 months ago (Feb. 29, 2008, 9:37 p.m.) |
Deposited | 3 years, 6 months ago (Feb. 23, 2022, 11:57 a.m.) |
Indexed | 1 month ago (Aug. 3, 2025, 12:03 a.m.) |
Issued | 17 years, 4 months ago (May 1, 2008) |
Published | 17 years, 4 months ago (May 1, 2008) |
Published Print | 17 years, 4 months ago (May 1, 2008) |
@article{Wang_2008, title={Dramatic Activation of Antibiotic Production in Streptomyces coelicolor by Cumulative Drug Resistance Mutations}, volume={74}, ISSN={1098-5336}, url={http://dx.doi.org/10.1128/aem.02800-07}, DOI={10.1128/aem.02800-07}, number={9}, journal={Applied and Environmental Microbiology}, publisher={American Society for Microbiology}, author={Wang, Guojun and Hosaka, Takeshi and Ochi, Kozo}, year={2008}, month=may, pages={2834–2840} }